Electromed Cost Of Revenue vs Interest Expense Analysis

ELMD Stock

USD 16.65 0.11 0.67%

Electromed financial indicator trend analysis is much more than just examining Electromed latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Electromed is a good investment. Please check the relationship between Electromed Cost Of Revenue and its Interest Expense accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.

Cost Of Revenue vs Interest Expense

Cost Of Revenue vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Electromed Cost Of Revenue account and Interest Expense. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Electromed's Cost Of Revenue and Interest Expense is -0.14. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Interest Expense in the same time period over historical financial statements of Electromed, assuming nothing else is changed. The correlation between historical values of Electromed's Cost Of Revenue and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Electromed are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Cost Of Revenue i.e., Electromed's Cost Of Revenue and Interest Expense go up and down completely randomly.

Correlation Coefficient

-0.14

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Electromed income statement and represents the costs associated with goods and services Electromed provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Most indicators from Electromed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Electromed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.At present, Electromed's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 17.06, whereas Tax Provision is forecasted to decline to about 954.9 K.

	2021	2022	2023	2024 (projected)
Interest Expense	25K	78K	89.7K	85.2K
Depreciation And Amortization	628K	613K	705.0K	669.7K

Interest Expense Depreciation And Amortization

Electromed fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		-0.71	-0.3	0.75	0.86	0.85	-0.74	0.86	0.88	0.77	0.89	0.31	0.8	0.77	0.82	0.76	0.84	-0.79	0.89	0.63	0.76	0.71	0.84	0.86	-0.21	-0.29
Short Long Term Debt Total	-0.71		0.24	-0.49	-0.79	-0.6	0.86	-0.76	-0.46	-0.77	-0.6	-0.24	-0.66	-0.77	-0.65	-0.7	-0.76	0.89	-0.59	-0.34	-0.7	-0.16	-0.59	-0.74	0.66	0.29
Other Current Liab	-0.3	0.24		-0.26	-0.21	-0.21	0.22	-0.22	-0.38	-0.19	-0.25	-1.0	-0.32	-0.19	-0.23	-0.07	-0.11	0.22	-0.16	-0.53	-0.16	-0.31	-0.21	-0.23	0.1	0.12
Total Current Liabilities	0.75	-0.49	-0.26		0.88	0.69	-0.44	0.89	0.83	0.42	0.73	0.26	0.93	0.42	0.96	0.57	0.62	-0.59	0.69	0.91	0.5	0.82	0.69	0.92	-0.05	-0.4
Total Stockholder Equity	0.86	-0.79	-0.21	0.88		0.73	-0.75	0.99	0.74	0.7	0.76	0.22	0.93	0.7	0.97	0.76	0.83	-0.85	0.75	0.72	0.68	0.58	0.72	0.99	-0.27	-0.35
Property Plant And Equipment Net	0.85	-0.6	-0.21	0.69	0.73		-0.4	0.7	0.87	0.4	0.99	0.21	0.73	0.4	0.75	0.77	0.76	-0.57	0.89	0.66	0.72	0.71	1.0	0.71	-0.33	-0.09
Net Debt	-0.74	0.86	0.22	-0.44	-0.75	-0.4		-0.76	-0.39	-0.98	-0.43	-0.22	-0.59	-0.98	-0.58	-0.56	-0.69	0.89	-0.53	-0.23	-0.6	-0.16	-0.38	-0.72	0.39	0.4
Retained Earnings	0.86	-0.76	-0.22	0.89	0.99	0.7	-0.76		0.73	0.72	0.73	0.23	0.95	0.72	0.97	0.68	0.76	-0.81	0.73	0.72	0.6	0.61	0.69	0.99	-0.27	-0.46
Accounts Payable	0.88	-0.46	-0.38	0.83	0.74	0.87	-0.39	0.73		0.42	0.91	0.38	0.77	0.42	0.8	0.67	0.7	-0.56	0.85	0.83	0.69	0.9	0.87	0.76	-0.03	-0.18
Cash	0.77	-0.77	-0.19	0.42	0.7	0.4	-0.98	0.72	0.42		0.44	0.19	0.55	1.0	0.54	0.55	0.68	-0.83	0.56	0.2	0.59	0.24	0.38	0.69	-0.28	-0.42
Non Current Assets Total	0.89	-0.6	-0.25	0.73	0.76	0.99	-0.43	0.73	0.91	0.44		0.25	0.76	0.44	0.78	0.79	0.79	-0.6	0.9	0.7	0.76	0.75	0.99	0.75	-0.27	-0.07
Non Currrent Assets Other	0.31	-0.24	-1.0	0.26	0.22	0.21	-0.22	0.23	0.38	0.19	0.25		0.33	0.19	0.23	0.08	0.12	-0.22	0.16	0.54	0.17	0.31	0.21	0.23	-0.1	-0.12
Other Assets	0.8	-0.66	-0.32	0.93	0.93	0.73	-0.59	0.95	0.77	0.55	0.76	0.33		0.55	0.96	0.57	0.64	-0.64	0.68	0.81	0.49	0.73	0.72	0.95	-0.33	-0.49
Cash And Short Term Investments	0.77	-0.77	-0.19	0.42	0.7	0.4	-0.98	0.72	0.42	1.0	0.44	0.19	0.55		0.54	0.55	0.68	-0.83	0.56	0.2	0.59	0.24	0.38	0.69	-0.28	-0.42
Net Receivables	0.82	-0.65	-0.23	0.96	0.97	0.75	-0.58	0.97	0.8	0.54	0.78	0.23	0.96	0.54		0.69	0.74	-0.72	0.73	0.83	0.6	0.71	0.74	0.98	-0.18	-0.34
Common Stock Total Equity	0.76	-0.7	-0.07	0.57	0.76	0.77	-0.56	0.68	0.67	0.55	0.79	0.08	0.57	0.55	0.69		0.98	-0.79	0.8	0.48	0.94	0.37	0.77	0.72	-0.17	0.2
Common Stock Shares Outstanding	0.84	-0.76	-0.11	0.62	0.83	0.76	-0.69	0.76	0.7	0.68	0.79	0.12	0.64	0.68	0.74	0.98		-0.85	0.81	0.49	0.93	0.41	0.75	0.79	-0.19	0.03
Non Current Liabilities Total	-0.79	0.89	0.22	-0.59	-0.85	-0.57	0.89	-0.81	-0.56	-0.83	-0.6	-0.22	-0.64	-0.83	-0.72	-0.79	-0.85		-0.67	-0.45	-0.81	-0.26	-0.56	-0.81	0.26	0.2
Inventory	0.89	-0.59	-0.16	0.69	0.75	0.89	-0.53	0.73	0.85	0.56	0.9	0.16	0.68	0.56	0.73	0.8	0.81	-0.67		0.63	0.79	0.68	0.89	0.74	-0.14	-0.14
Other Current Assets	0.63	-0.34	-0.53	0.91	0.72	0.66	-0.23	0.72	0.83	0.2	0.7	0.54	0.81	0.2	0.83	0.48	0.49	-0.45	0.63		0.45	0.81	0.66	0.76	0.05	-0.23
Other Stockholder Equity	0.76	-0.7	-0.16	0.5	0.68	0.72	-0.6	0.6	0.69	0.59	0.76	0.17	0.49	0.59	0.6	0.94	0.93	-0.81	0.79	0.45		0.36	0.72	0.65	-0.15	0.2
Total Liab	0.71	-0.16	-0.31	0.82	0.58	0.71	-0.16	0.61	0.9	0.24	0.75	0.31	0.73	0.24	0.71	0.37	0.41	-0.26	0.68	0.81	0.36		0.72	0.64	0.11	-0.34
Property Plant And Equipment Gross	0.84	-0.59	-0.21	0.69	0.72	1.0	-0.38	0.69	0.87	0.38	0.99	0.21	0.72	0.38	0.74	0.77	0.75	-0.56	0.89	0.66	0.72	0.72		0.7	-0.32	-0.08
Total Current Assets	0.86	-0.74	-0.23	0.92	0.99	0.71	-0.72	0.99	0.76	0.69	0.75	0.23	0.95	0.69	0.98	0.72	0.79	-0.81	0.74	0.76	0.65	0.64	0.7		-0.22	-0.39
Short Term Debt	-0.21	0.66	0.1	-0.05	-0.27	-0.33	0.39	-0.27	-0.03	-0.28	-0.27	-0.1	-0.33	-0.28	-0.18	-0.17	-0.19	0.26	-0.14	0.05	-0.15	0.11	-0.32	-0.22		0.32
Intangible Assets	-0.29	0.29	0.12	-0.4	-0.35	-0.09	0.4	-0.46	-0.18	-0.42	-0.07	-0.12	-0.49	-0.42	-0.34	0.2	0.03	0.2	-0.14	-0.23	0.2	-0.34	-0.08	-0.39	0.32

Click cells to compare fundamentals

Electromed Account Relationship Matchups

Electromed fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.2M	37.1M	41.4M	45.8M	52.7M	26.4M
Short Long Term Debt Total	81.2K	87K	41K	161K	144.9K	137.7K
Other Current Liab	2.4M	4.0M	(1.5B)	6.7M	6.0M	6.3M
Total Current Liabilities	3.0M	4.6M	7.2M	8.1M	9.3M	9.7M
Total Stockholder Equity	30.2M	32.4M	34.2M	37.7M	43.3M	45.5M
Property Plant And Equipment Net	3.9M	3.7M	4.7M	5.7M	6.5M	3.9M
Net Debt	(10.4M)	(11.8M)	(8.1M)	(7.2M)	(6.5M)	(6.2M)
Retained Earnings	13.7M	14.9M	15.8M	18.8M	21.6M	22.7M
Accounts Payable	555.5K	685K	1.3M	1.4M	1.6M	795.8K
Cash	10.5M	11.9M	8.2M	7.4M	8.5M	5.3M
Non Current Assets Total	5.2M	5.4M	6.8M	8.0M	9.2M	5.4M
Non Currrent Assets Other	80.2K	88K	120M	161K	185.2K	175.9K
Other Assets	755K	1.1M	1.5M	1.6M	1.8M	1.9M
Cash And Short Term Investments	10.5M	11.9M	8.2M	7.4M	8.5M	5.3M
Net Receivables	14.1M	17.4M	21.3M	24.6M	28.3M	29.7M
Common Stock Total Equity	84.1K	85.7K	85K	86K	98.9K	86.6K
Common Stock Shares Outstanding	8.8M	8.9M	8.8M	8.7M	10.0M	8.8M
Liabilities And Stockholders Equity	33.2M	37.1M	41.4M	45.8M	52.7M	26.4M
Non Current Liabilities Total	8.9K	54K	41K	86K	77.4K	73.5K
Inventory	3.1M	2.1M	3.2M	4.2M	4.9M	2.5M
Other Current Assets	353.3K	276K	2.2M	1.6M	1.8M	1.9M
Other Stockholder Equity	16.5M	17.4M	18.3M	18.8M	21.6M	16.1M
Total Liab	3.0M	4.7M	7.2M	8.1M	9.4M	5.4M
Property Plant And Equipment Gross	3.8M	3.6M	4.7M	5.7M	6.5M	3.9M
Total Current Assets	28.0M	31.7M	34.5M	37.8M	43.5M	45.6M
Short Term Debt	30.3K	72.3K	33K	80K	72K	68.4K
Intangible Assets	598.4K	663K	599K	605K	544.5K	517.3K
Common Stock	84.1K	85.7K	85K	86K	98.9K	86.6K
Property Plant Equipment	3.9M	3.6M	4.6M	5.7M	6.5M	3.9M
Current Deferred Revenue	(72.3K)	(33K)	1.5B	(80K)	(92K)	(87.4K)
Net Tangible Assets	29.7M	31.8M	33.6M	37.1M	42.6M	24.2M
Retained Earnings Total Equity	13.7M	14.9M	15.8M	18.8M	21.6M	22.7M
Capital Surpluse	16.5M	17.4M	18.3M	18.8M	21.6M	16.7M
Net Invested Capital	30.2M	32.4M	34.2M	37.7M	43.3M	32.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

OEPIX	Oil Equipment Services
MMM	3M Company
SLV	iShares Silver Trust

When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:

How To Invest In Electromed

Details

Is Electromed Stock a good investment?

Details

What is Electromed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.

You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Electromed Stock analysis

When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.

	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios

Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.417

Earnings Share

0.49

Revenue Per Share

6.265

Quarterly Revenue Growth

0.149

Return On Assets

0.0782

The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Electromed Cost Of Revenue vs Interest Expense Analysis

Cost Of Revenue vs Interest Expense

Cost Of Revenue vs Interest Expense Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Interest Expense

Electromed fundamental ratios Correlations

Electromed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Electromed fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Electromed Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Retained Earnings	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Total Stockholder Equity
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Retained Earnings

Non Currrent Assets Other	- 1.0	Other Current Liab
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Non Current Liabilities Total	- 0.85	Common Stock Shares Outstanding
Non Current Liabilities Total	- 0.85	Total Stockholder Equity
Non Current Liabilities Total	- 0.83	Cash And Short Term Investments